Summit Tx Capital, L.P. Vera Therapeutics, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 128,579 shares of VERA stock, worth $2.73 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
128,579Holding current value
$2.73 Million% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$121 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$101 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70.9 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$62.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$62 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $574M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...